Fight against sepsis: Fibrin, a product of the blood clotting process, is key to protection during gram-negative sepsis

New research may help to explain why anticoagulant therapies have largely failed to extend the lives of patients with sepsis. The study shows that fibrin, a key product of the blood clotting process, is critical for host defense against Yersinia enterocolitica, a gram-negative bacterium that causes sepsis in humans and experimental mice.

Read the whole article on Science Daily

More from Science Daily